GlassScriptPhysician profile
Jacob Taft Malone
NPI 1851043947
$3,262.74
in general payments reported to CMS, 2019-2025
30 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.15 · 2023: $1,071 · 2024: $775 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,206.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.23 | 2022-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $307.18 | 2023-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $262.74 | 2023-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $254.25 | 2025 | Camzyos |
| Novo Nordisk INC | $206.24 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Atricure, INC. | $188.87 | 2024 | |
| Novartis Pharmaceuticals Corporation | $186.30 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $170.82 | 2023-2025 | Andexxa, Wainua |
| Edwards Lifesciences Corporation | $160.01 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $139.68 | 2023-2025 | Repatha, Repatha |
| Abiomed | $136.33 | 2023-2025 | Impella |
| Daiichi Sankyo INC. | $128.95 | 2023-2025 | Injectafer |
| Boston Scientific Corporation | $93.45 | 2023-2024 | Watchman Access System |
| Abbott Laboratories | $90.40 | 2024 | Jot Dx |
| Lexicon Pharmaceuticals, INC. | $87.91 | 2023-2024 | Inpefa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $77.02 | 2025 | |
| Medtronic, INC. | $74.99 | 2022-2023 | Micra, Linq II |
| Philips North America LLC | $33.71 | 2025 | Mcot |
| Lilly USA, LLC | $32.09 | 2025 | Zepbound |
| Pfizer INC. | $30.32 | 2023-2025 | |
| Chiesi USA, INC. | $29.63 | 2023-2024 | Kengreal, Cleviprex |
| Janssen Pharmaceuticals, INC | $29.06 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.90 | 2023 | Jardiance |
| Axsome Therapeutics, INC. | $23.93 | 2025 | Symbravo |
| Altathera Pharmaceuticals LLC | $23.76 | 2023 | Sotalol Hydrochloride |
| Cvrx, INC. | $23.00 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $21.14 | 2023 | |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $17.91 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $14.86 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.